PRESENTATION

Q3 FY2020 — Presentation

Q3 FY2020PDF · 20 pages545 KB
© 2020 Lam Research Corp. | 4.22.2020 	1
Lam Research Corporation
March Quarter 2020 Financial Results
April 22, 2020

-- 1 of 20 --

© 2020 Lam Research Corp. | 4.22.2020 	2
Cautionary Statement Regarding Forward-Looking Statements
This presentation and the accompanying discussion contain “forward-looking statements” under U.S. securities laws. Forward-looking
statements include any statements that are not statements of historical fact. Examples of forward-looking statements include, but are not
limited to: (1) anticipated business, balance sheet, cash flow and financial measures and results, including guidance, whether on a GAAP or
non-GAAP basis; (2) economic, market, industry and industry segment expectations; (3) product performance and changes in market share or
customer demands; (4) our ability to successfully execute business, capital allocation, product and growth plans or strategies, or otherwise
deliver value for customers and stockholders; and (5) the impact of the COVID-19 pandemic on our operations and financial results, and our
ability to mitigate operational and business impacts caused by it. 	Forward-looking statements speak only as of the date they are made and are
subject to risks and uncertainties that could cause actual results to differ materially from those expressed, including: the severity, magnitude
and duration of the COVID–19 pandemic (and the related governmental, public health, business and community responses to it), and their
impacts on our business, results of operations and financial condition, are evolving and are highly uncertain and unpredictable; business,
political and/or regulatory conditions in the consumer electronics industry, the semiconductor industry and the overall economy may
deteriorate or change; the actions of our customers and competitors may be inconsistent with our expectations; and widespread outbreaks of
illness may impact our operations and revenue in affected areas; as well as the other factors discussed in our filings with the Securities and
Exchange Commission (“SEC”), including specifically the Risk Factors described in our annual report on Form 10–K for the fiscal year ended June
30, 2019, our quarterly reports on Form 10–Q for the fiscal quarters ended September 29, 2019 and December 29, 2019, and our current report
of Form 8–K dated April 22, 2020. 	You should not place undue reliance on forward-looking statements. Lam undertakes no obligation to update
any forward-looking statements.

-- 2 of 20 --

© 2020 Lam Research Corp. | 4.22.2020 	3
Business Review and Industry Outlook
Tim Archer
President and Chief Executive Officer

-- 3 of 20 --

© 2020 Lam Research Corp. | 4.22.2020 	4
Areas of Focus
Supporting Critical Customer Needs
Implement business continuity plans in manufacturing and supply chain
network
Increase the capability and expertise of regional teams to meet
customers’ installed-base and new system installation needs
Ensure health and safety of our employees, partners, and their families
Created $25 million COVID-19 Relief Fund for employees and communities

-- 4 of 20 --

© 2020 Lam Research Corp. | 4.22.2020 	5
*Data calculated on a non-GAAP basis. Reconciliations of U.S. GAAP results to non-GAAP results can be found at the end of this presentation.
March 2020
Quarter Results $2.50B
Revenue
$3.98
Earnings per Share*
Solid Execution in the March Quarter

-- 5 of 20 --

© 2020 Lam Research Corp. | 4.22.2020 	6
► Strong customer demand environment but
equipment industry is supply constrained
► Exiting March quarter with record backlog
► Cloud and enterprise-related demand offset by
weak consumer markets
► Underinvestment in supply in 2019 provides
confidence in healthy memory market
fundamentals
► Lam well-positioned to deliver on long-term
strategy
Industry Overview

-- 6 of 20 --

© 2020 Lam Research Corp. | 4.22.2020 	7
Installed Base 	Share 	Served Available Market
Strategy for Outperformance
 	Solid foundation with
revenues ($856M in
March) growing faster
than installed-base units
 	Continued strong activity
in Reliant®
 	Wins in Etch across DRAM,
NAND, Foundry/Logic
 	Customer pull for Sense.i™,
our etch platform with
advanced equipment
intelligence, data analysis
and self-maintenance
capabilities
 	Atomic layer deposition
(ALD) for advanced logic
nodes and 3D NAND gapfill

-- 7 of 20 --

© 2020 Lam Research Corp. | 4.22.2020 	8
Summary
Confident in long-term secular demand for
semiconductors driving WFE growth
Executing well in challenging environment
Continued focus on mitigating operational impacts

-- 8 of 20 --

© 2020 Lam Research Corp. | 4.22.2020 	9
March Quarter 2020 Financial Results
and June Quarter 2020 Outlook
Doug Bettinger
Executive Vice President and Chief Financial Officer

-- 9 of 20 --

© 2020 Lam Research Corp. | 4.22.2020 	10
Revenue
Earnings per Share*
Revenue
Revenue
March Quarter Results
*Data are presented on a non-GAAP basis. Reconciliations of U.S. GAAP results to non-GAAP results can be found at the end of this presentation.
$3.98
QMar'20 	QDec'19
$4.01
EPS ($)
$2.50 $2.58
QMar'20 	QDec'19
Revenue ($B)

-- 10 of 20 --

© 2020 Lam Research Corp. | 4.22.2020 	11
March Quarter Revenue Mix
Revenue
Revenue by Region
Revenue
System Revenue Segments *
40%
16%
13%
31 %
Foundry
Logic/Other
Memory
56%
NVM China
32%
Korea
23%
Taiwan
21%
Japan
10%
US
9%
Europe 3%
DRAM
NVM = Non-Volatile Memory
* Systems revenue includes equipment and equipment upgrade sales from etch, deposition, clean and our Reliant product line
► Increases in Memory investments; Foundry strength continued
SEA 2%

-- 11 of 20 --

© 2020 Lam Research Corp. | 4.22.2020 	12
March Quarter Financial Results
Q Mar’20 	Q Dec’19
Revenue 	$2,504M 	$2,584M
Non-GAAP Gross Margin* 	46.3% 	45.7%
Non-GAAP Operating Expenses* 	$486M 	$481M
Non-GAAP Operating Income* 	$673M 	$700M
Non-GAAP Operating Income as a percentage of
Revenue* 26.9% 	27.1%
Non-GAAP Other Expense, Net* 	$30M 	$13M
Non-GAAP Tax Rate* 	8.3% 	12.5%
U.S. GAAP Diluted EPS 	$3.88 	$3.43
Non-GAAP Diluted EPS* 	$3.98 	$4.01
Diluted Share Count 	148M 	150M
*A reconciliation of U.S. GAAP results to non-GAAP results can be found at the end of this presentation.

-- 12 of 20 --

© 2020 Lam Research Corp. | 4.22.2020 	13
Key Balance Sheet and Financial Metrics
Q Mar’20 	Q Dec’19
Total Consolidated Gross Cash Balance 	$5,647M 	$4,938M
Account Receivables, Net 	$2,191M 	$2,030M
DSO 	80 Days 	72 Days
Inventory Turns 	3.2 	3.7
Deferred Revenue* 	$726M 	$411M
Capital Expenditures 	$51M 	$62M
Equity Compensation Expense 	$47M 	$46M
Amortization Expense 	$17M 	$17M
Depreciation Expense 	$50M 	$49M
Headcount 	~11,000 	~10,700
* Lam’s deferred revenue balance does not include shipments to customers in Japan, to whom title does not transfer until customer acceptance.
Estimated future revenue from shipments to customers in Japan was approx. $115M as of March 29, 2020 and $91M as of December 29, 2019.

-- 13 of 20 --

© 2020 Lam Research Corp. | 4.22.2020 	14
► Customer demand strong, but currently output constrained
► Expect June quarter revenues to be higher than March with
current operational performance
► Capacity challenges negatively impact gross margin
► CSBG business remains resilient
► Actively managing costs with increased spending focused on
health and safety of employees and partners and critical
customer needs
► Higher interest expense related to revolver draw
► Flat share count
June 2020 Quarter Outlook

-- 14 of 20 --

© 2020 Lam Research Corp. | 4.22.2020 	15
Questions and Answers

-- 15 of 20 --

© 2020 Lam Research Corp. | 4.22.2020 	16
Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income
(in thousands, except per share data)
(unaudited)
Three Months Ended
March 29,
2020 December 29,
2019 December 29,
2019
(As Previously
Presented) 	(As Adjusted)
U.S. GAAP net income 	$ 	574,781 	$ 	514,510 	$ 	514,510
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business
combinations - cost of goods sold 	1,627 	1,627 	1,627
(Gain) loss on elective deferred compensation ("EDC") - related liability - cost of
goods sold 	(8,653) 	— 	3,587
(Gain) loss on EDC - related liability - research and development 	(15,575) 	— 	6,456
Amortization related to intangible assets acquired through certain business
combinations - selling, general and administrative 	12,357 	12,357 	12,357
(Gain) loss on EDC - related liability - selling, general and administrative 	(10,383) 	— 	4,304
Amortization of note discounts - other expense, net 	953 	1,158 	1,158
Loss (gain) on EDC - related asset - other expense, net 	33,828 	— 	(14,129 )
Net income tax expense (benefit) on non-GAAP items 	1,700 	(2,358) 	(4,029 )
Income tax benefit on the conclusion of certain tax matters 	(276) 	— 	—
Cumulative income tax benefit reversal due to a court ruling 	— 	74,516 	74,516
Non-GAAP net income 	$ 	590,359 	$ 	601,810 	$ 	600,357
Non-GAAP net income per diluted share 	$ 	3.98 	$ 	4.01 	$ 	4.00
U.S. GAAP net income per diluted share 	$ 	3.88 	$ 	3.43 	$ 	3.43
U.S. GAAP and non-GAAP number of shares used for per diluted share calculation 	148,165 	150,097 	150,097
Appendix – Reconciliation

-- 16 of 20 --

© 2020 Lam Research Corp. | 4.22.2020 	17
Three Months Ended
March 29,
2020 December 29,
2019 December 29,
2019
(As Previously
Presented) 	(As Adjusted)
U.S. GAAP gross margin 	$ 	1,167,007 	$ 	1,179,644 	$ 	1,179,644
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business
combinations 	1,627 	1,627 	1,627
(Gain) loss on EDC-related liability 	(8,653) 	— 	3,587
Non-GAAP gross margin 	$ 	1,159,981 	$ 	1,181,271 	$ 	1,184,858
U.S. GAAP gross margin as a percentage of revenue 	46.6% 	45.7% 	45.7%
Non-GAAP gross margin as a percentage of revenue 	46.3% 	45.7% 	45.9%
U.S. GAAP operating expenses 	$ 	472,893 	$ 	493,133 	$ 	493,133
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business
combinations 	(12,357) 	(12,357) 	(12,357)
Gain (loss) on EDC-related liability 	25,958 	— 	(10,760)
Non-GAAP operating expenses 	$ 	486,494 	$ 	480,776 	$ 	470,016
U.S. GAAP operating income 	$ 	694,114 	$ 	686,511 	$ 	686,511
Non-GAAP operating income 	$ 	673,487 	$ 	700,495 	$ 	714,842
U.S. GAAP operating income as percent of revenue 	27.7% 	26.6% 	26.6%
Non-GAAP operating income as a percent of revenue 	26.9% 	27.1% 	27.7%
Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Income to Non-GAAP Gross Margin,
Operating Expenses and Operating Income
(in thousands, except percentages)
(unaudited)
Appendix – Reconciliation

-- 17 of 20 --

© 2020 Lam Research Corp. | 4.22.2020 	18
Reconciliation of U.S. GAAP Other Expense, Net to Non-GAAP Other Expense, Net
(in thousands)
(unaudited)
Three Months Ended
March 29,
2020 December 29,
2019 December 29,
2019
(As Previously
Presented) 	(As Adjusted)
U.S. GAAP Other expense, net 	$ 	(64,619) $ 	(13,924) 	$ 	(13,924)
Pre-tax non-GAAP items:
Amortization of note discounts 	953 	1,158 	1,158
Loss (gain) on EDC - related asset - other expense, net 	33,828 	— 	(14,129)
Non-GAAP Other expense, net $ 	(29,838) $ 	(12,766) 	$ 	(26,895)
Appendix – Reconciliation

-- 18 of 20 --

© 2020 Lam Research Corp. | 4.22.2020 	19
Reconciliation of U.S. GAAP Income Tax Rate to Non-GAAP Income Tax Rate
(in thousands, except percentages)
(unaudited)
Three Months Ended
March 29,
2020 December 29,
2019 December 29,
2019
(As Previously
Presented) 	(As Adjusted)
U.S. GAAP income before income taxes 	$ 	629,495 	$ 	672,587 	$ 	672,587
U.S. GAAP income tax expense 	$ 	54,714 	$ 	158,077 	$ 	158,077
U.S. GAAP income tax rate 	8.7% 	23.5% 	23.5%
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain
business combinations - cost of goods sold 	$ 	1,627 	$ 	1,627 	$ 	1,627
(Gain) loss on elective deferred compensation ("EDC") - related
liability - cost of goods sold 	(8,653) 	— 	3,587
(Gain) loss on EDC - related liability - research and development 	(15,575) 	— 	6,456
Amortization related to intangible assets acquired through certain
business combinations - selling, general and administrative 	12,357 	12,357 	12,357
(Gain) loss on EDC - related liability - selling, general and
administrative 	(10,383) 	— 	4,304
Amortization of note discounts - other expense, net 	953 	1,158 	1,158
Loss (gain) on EDC - related asset - other expense, net 	33,828 	— 	(14,129)
Non-GAAP income before taxes 	$ 	643,649 	$ 	687,729 	$ 	687,947
Net income tax (expense) benefit on non-GAAP items 	$ 	(1,700) 	$ 	2,358 	$ 	4,029
Income tax benefit on conclusion of certain tax matters 	276 	— 	—
Cumulative income tax benefit reversal due to a court ruling 	— 	(74,516) 	(74,516)
Non-GAAP income tax expense 	$ 	53,290 	$ 	85,919 	$ 	87,590
Non-GAAP income tax rate 	8.3% 	12.5% 	12.7%
Appendix – Reconciliation

-- 19 of 20 --



-- 20 of 20 --